JG
OLMA icon

Jain Global’s Olema Pharmaceuticals OLMA Stock Holding History

Jain Global’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,160
Closed -$754K – 1529
2025
Q4 		$754K Buy
+30,160
New +$537K ﹤0.01% 754
2025
Q2 		– Sell
-12,396
Closed -$46.6K – 1505
2025
Q1 		$46.6K Buy
+12,396
New +$62.3K ﹤0.01% 1008

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Jain Global's OLMA Position: Q1 2026 in Review

Jain Global sold out of Olema Pharmaceuticals (OLMA) in Q1 2026, closing a stake of 30,160 shares — an estimated $754K sold.

Jain Global first reported a position in OLMA in Q1 2025 and held it in 2 quarters. The position peaked at $754K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Jain Global reported no remaining Olema Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jain Global sold 30,160 Olema Pharmaceuticals shares in Q1 2026, an estimated $754K.
  • Jain Global first reported a position in Olema Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • Jain Global's Olema Pharmaceuticals position peaked at $754K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.